Moleculin Biotech Statistics
Total Valuation
MBRX has a market cap or net worth of $6.57 million. The enterprise value is -$606,384.
Important Dates
The last earnings date was Monday, November 16, 2026, before market open.
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MBRX has 973,869 shares outstanding. The number of shares has increased by 916.15% in one year.
| Current Share Class | 973,869 |
| Shares Outstanding | 973,869 |
| Shares Change (YoY) | +916.15% |
| Shares Change (QoQ) | +161.24% |
| Owned by Insiders (%) | 6.70% |
| Owned by Institutions (%) | 4.42% |
| Float | 838,609 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.49 |
| P/TBV Ratio | 1.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.37 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -89.99% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -202.59% |
| Weighted Average Cost of Capital (WACC) | 15.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$509,294 |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.81% in the last 52 weeks. The beta is 2.09, so MBRX's price volatility has been higher than the market average.
| Beta (5Y) | 2.09 |
| 52-Week Price Change | -96.81% |
| 50-Day Moving Average | 9.47 |
| 200-Day Moving Average | 35.16 |
| Relative Strength Index (RSI) | 36.33 |
| Average Volume (20 Days) | 34,348 |
Short Selling Information
The latest short interest is 54,541, so 5.60% of the outstanding shares have been sold short.
| Short Interest | 54,541 |
| Short Previous Month | 126,324 |
| Short % of Shares Out | 5.60% |
| Short % of Float | 6.50% |
| Short Ratio (days to cover) | 1.27 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -29.58M |
| Pretax Income | -11.42M |
| Net Income | -8.66M |
| EBITDA | -29.55M |
| EBIT | -29.58M |
| Earnings Per Share (EPS) | -$42.13 |
Full Income Statement Balance Sheet
The company has $7.29 million in cash and $107,000 in debt, with a net cash position of $7.18 million or $7.37 per share.
| Cash & Cash Equivalents | 7.29M |
| Total Debt | 107,000 |
| Net Cash | 7.18M |
| Net Cash Per Share | $7.37 |
| Equity (Book Value) | 14.49M |
| Book Value Per Share | 13.86 |
| Working Capital | 2.28M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -27.10M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 33,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -27.10M |
| FCF Per Share | -$27.83 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MBRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -916.15% |
| Shareholder Yield | -916.15% |
| Earnings Yield | -624.09% |
| FCF Yield | -407.49% |
Analyst Forecast
The average price target for MBRX is $240.00, which is 3,455.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $240.00 |
| Price Target Difference | 3,455.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on October 20, 2026. It was a reverse split with a ratio of 1:20.
| Last Split Date | Oct 20, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |